Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 3 Hyperthermia 3 Uterine Cervical Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Sarcoma, Synovial 1 Sarcoma 1 Rhabdomyosarcoma 1 Peritoneal Neoplasms 1 Neurofibrosarcoma 1 Neoplasm Metastasis 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemorrhage 1 Hemangiosarcoma 1 Fibrosarcoma 1 Condylomata Acuminata 1 Bone Neoplasms 1 Anus Neoplasms 1

Interventions

Tranexamic Acid 5 Sodium Chloride 2 Saline Solution 2 Misoprostol 2 bemiparin 1 Solutions 1 Proton Pump Inhibitors 1 Oxytocin 1 N(4)-oleylcytosine arabinoside 1 Lansoprazole 1 Injections, Intravenous 1 Goserelin 1 Gonadotropin-Releasing Hormone 1 Fibrin Tissue Adhesive 1 Diathermy 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hemorrhage × Diathermy × Clear all

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡